Safety And Tolerability Study Of RN564 In Women With Osteopenia And Healthy Men.

Completed · Phase 1

Conditions studied: Osteopenia, Osteoporosis, Bone Disease

In brief

The purpose of this study is to determine the safety and tolerability of RN564 in women with osteopenia and healthy men.

Key facts

Study ID
NCT01293487
Run by
Pfizer
People needed
68
Starts
2011-04-01
Expected to finish
2012-05-24
Last updated by the study team
2024-09-24

Who can join

Age: 55 and older, up to 80. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.